An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer Patients
Clinical trial NCT04885413 · UNKNOWN
Trial details
- NCT number
- NCT04885413
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2022-08-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.